Lifting the Veil on Suicidal Ideation and Behavior in Psoriasis

August 2018 | Volume 17 | Issue 8 | Department | 27 | Copyright © August 2018

Kircik, L.H. et al.

.

Abstract
Research into the immunopathological mechanisms of plaque psoriasis has produced increasingly targeted biologic therapies. The specificity of these agents allows for high rates of efficacy and decreased adverse events, most notably reduced immune system suppression. In recent years, the recognition of interleukin (IL)-17 as an important component in the pathogenesis of psoriasis has led to the development of a new class of biologics.